Question 1

Am I eligible for this trial based on my current health and treatment history?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen clinical trial (NCT00135343). Contact the study team or your healthcare provider for specific answers.

Question 2

What are the potential side effects of the medications being tested?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen clinical trial (NCT00135343). Contact the study team or your healthcare provider for specific answers.

Question 3

How does this treatment compare to other options available for me?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen clinical trial (NCT00135343). Contact the study team or your healthcare provider for specific answers.

Question 4

What will the treatment schedule look like, and how often will I need to visit the clinic?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen clinical trial (NCT00135343). Contact the study team or your healthcare provider for specific answers.

Question 5

What kind of monitoring will be done during the trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen clinical trial (NCT00135343). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any specific lifestyle changes I should consider while participating?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Pilot Study of Atazanavir/Ritonavir/Efavirenz as a Nucleoside Sparing Regimen clinical trial (NCT00135343). Contact the study team or your healthcare provider for specific answers.

What this study is about